Jacob Van Naarden headshot
Jacob S. Van Naarden
Executive Vice President; President of Lilly Oncology and Head of Corporate Business Development, Eli Lilly and Company
Download bio
asset
Download Jacob Van Naarden's Bio
spacer
large
spacer
medium
Jake Van Naarden serves as executive vice president, president of Lilly Oncology and head of corporate business development for Eli Lilly and Company. Jake oversees all aspects of oncology spanning discovery through commercial and has responsibility for Lilly’s corporate business development function.
32px
spacer
small
spacer
small
Jake joined Lilly in 2019 when the company acquired Loxo Oncology, Inc., where he was the chief operating officer. Following the acquisition, Jake played a key role in establishing the oncology research and development program.
16px
spacer
small
In his earlier roles, Jake worked in various biotechnology investing, operational, and advisory capacities, including positions with HealthCor Management, Aisling Capital and Goldman Sachs.
16px
spacer
large
spacer
medium
Jake received his A.B. degree in molecular biology from Princeton University.
32px
spacer
medium
medium
spacer
large
medium
Daniel M. Skovronsky
link
Daniel M. Skovronsky
Ilya Yuffa
link
Ilya Yuffa